Metastatic castration-resistant prostate cancer (mCRPC) SURVEY

$300 paid to participants! We are inviting individuals diagnosed with mCRPC and their care partner, caregiver, or family member to take part in a a market research study on metastatic castration-resistant prostate cancer (mCRPC). Malecare has worked with this research group before and feels that their work helps advance therapies and treatments for our prostate cancer community. The study consists of two separate 1-hour virtual interviews — one with the patient and one with their care partner. ENTER YOUR EMAIL — A LINK TO THE SURVEY WILL THEN APPEAR IMMEDIATELY ON THIS WEBPAGE. THE LINK TAKES YOU TO A SHORT FIVE MINUTE FORM TO FILL OUT, TO SET YOU UP FOR THE SURVEY AT YOUR CONVENIENCE.

Share Your Experience

Online Interviews for People Living in the US with Metasta􏰀c Castra􏰀on-Resistant Prostate Cancer (mCRPC)

Who can take part?

􏰃􏰈􏰉􏰊 Individuals diagnosed with mCRPC
􏰔􏰕􏰖􏰗 Care partners, caregivers, or family members

About the study

􏰛 Online (virtual) interviews
􏰢􏰣 Around 120 minutes total
􏰦􏰧􏰨􏰩 $300 thank-you
􏰪􏰫􏰬􏰮􏰯 Scheduled at your convenience

Enter your correct email address – the survey link will immediately appear on this webpage.